Civitas was a private company but were planning to do an IPO just before buyout. So no pre or post price. Paying half billion for a company that has not even completed P3 tells me ACOR saw a huge market potential.
Cynapsus sublingual strip is lot safer and the data they published is very impressive.
I hope they plan to uplist to NASDAQ from OTCBB which will be another boost.